This can be amended after discussion with prescribing clinician
Studies show the peptide increases dendritic spine density by 40-60% in treated brain regions, with formation of new functional synaptic connections confirmed by electrophysiological recordings demonstrating enhanced synaptic transmission and long-term potentiation
Professional Use Only - This product is for professional use and should only be administered by a licensed healthcare professional
Maintenance Phase 1 NAD+ IV treatment every 46 weeks This phase sustains therapeutic NAD+ concentrations, supports ongoing neural regeneration, preserves cognitive performance, and maintains systemic metabolic efficiency over time
Its tan, dullness, uneven texture, melasma, or post-acne marks
Peptides are still experimental in many fertility applications and not part of standard of care